http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0414791-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-18
filingDate 2004-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db1c30ca5d5a6229c66afccb1eb5c16e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2db3b6f2a4781e386234593dc2acf12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_126819b06f34b71daaa389105f438fa5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a269773a695bc67fd4e38fcf025a788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd353bc9b009350567061c9d0ce4b4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c993519c4cc61aaa2920228e533f50eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ccb0d84506e3b24880608cb3e4010a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39c877cd5f3e3d1693817ca5555b717a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca18db9f6eb466d9c540e208b783791
publicationDate 2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0414791-A
titleOfInvention purine derivatives hiv replication inhibitors
abstract "PURINE DERIVATIVES INHIBITING HIV REPLICATION". The present invention relates to the use of a compound of formula (I) for the manufacture of a medicament for the prevention or treatment of HIV infection wherein the compound of formula (I) is a compound of formula (I), a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein A and B each represent a radical of formula (a) or (b) and wherein -CD- represents a radical bivalent of formula -N = CH-NR¬ 17¬- (c-1); or -NR¬ 17¬-CH = N- (c-2); provided that when A represents a radical of formula (a) then B represents a radical of formula (b) and when A represents a radical of formula (b) then B represents a radical of formula (a).
priorityDate 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457490455

Total number of triples: 29.